{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:35:00Z","timestamp":1794472500807,"version":"4.9.1"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Metab"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Therapy resistance is attributed to over 80% of cancer deaths per year, emphasizing the urgent need to overcome this challenge for improved patient outcomes. Despite its widespread use in colorectal cancer (CRC) treatment, resistance to 5-fluorouracil (5FU) remains poorly understood. As an antimetabolite, 5FU imposes substantial metabolic stress, forcing cells that survive treatment to rapidly adapt. We explored acute 5FU-driven changes in mitochondria, the organelle critical for coordinating metabolic stress responses. Here we demonstrate in a range of CRC models that 5FU treatment promotes mitochondrial biogenesis and increases mitochondrial function in surviving cells. Furthermore, we show that targeting mitochondrial metabolism, particularly by inhibiting Complex I, sensitizes CRC cells to 5FU, resulting in delayed tumour growth and prolonged survival in preclinical models. Additionally, analysis of patient data suggests that oxidative metabolism signatures may predict responses to 5FU-based chemotherapy. These findings shed light on mechanisms underlying 5FU resistance and propose a rational strategy for combination therapy in CRC, emphasizing the potential clinical benefit of targeting mitochondrial metabolism to overcome resistance and enhance patient outcomes.<\/jats:p>","DOI":"10.1038\/s42255-026-01578-w","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T09:05:39Z","timestamp":1784797539000},"page":"1751-1771","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Mitochondrial metabolism determines chemotherapy sensitivity in colorectal cancer"],"prefix":"10.1038","volume":"8","author":[{"given":"Deborah Y.","family":"Moss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8914-1358","authenticated-orcid":false,"given":"Connor N.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"McCann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6603-6251","authenticated-orcid":false,"given":"Nikita","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilda","family":"Downs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Wurelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciara","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Philips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niamh","family":"Doherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"McDaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Roe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisling Y.","family":"Coughlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1582-5756","authenticated-orcid":false,"given":"Brenton","family":"Cavanagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Callum","family":"Ormsby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiammetta","family":"Falcone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"McCole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Monteith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Rogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5862-3815","authenticated-orcid":false,"given":"Sudhir B.","family":"Malla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra J.","family":"Emerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letitia","family":"Mohammed-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun","family":"Sharkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoife","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter F.","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arindam","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Van Schaeybroeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sufyan","family":"Pandor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Greer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Maguire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5831-6783","authenticated-orcid":false,"given":"Aideen E.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9160-283X","authenticated-orcid":false,"given":"Philip D.","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Mallon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5476-751X","authenticated-orcid":false,"given":"Stephanie","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6271-1493","authenticated-orcid":false,"given":"Omar","family":"Aftab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura C.","family":"Greaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1874-6906","authenticated-orcid":false,"given":"Bryan P.","family":"Marzullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0499-2732","authenticated-orcid":false,"given":"Daniel A.","family":"Tennant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"Coyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian G.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9540-3010","authenticated-orcid":false,"given":"Owen","family":"Sansom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tr\u00edona","family":"N\u00ed Chonghaile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel B.","family":"Longley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon S.","family":"McDade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa J.","family":"LaBonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1952-4213","authenticated-orcid":false,"given":"Emma M.","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"1578_CR1","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","volume":"575","author":"N Vasan","year":"2019","unstructured":"Vasan, N., Baselga, J. & Hyman, D. M. A view on drug resistance in cancer. Nature 575, 299\u2013309 (2019).","journal-title":"Nature"},{"key":"1578_CR2","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.annonc.2020.06.022","volume":"31","author":"G Argil\u00e9s","year":"2020","unstructured":"Argil\u00e9s, G. et al. Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 31, 1291\u20131305 (2020).","journal-title":"Ann. Oncol."},{"key":"1578_CR3","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1200\/JCO.22.01690","volume":"41","author":"VK Morris","year":"2023","unstructured":"Morris, V. K. et al. Treatment of metastatic colorectal cancer: ASCO guideline. J. Clin. Oncol. 41, 678\u2013700 (2023).","journal-title":"J. Clin. Oncol."},{"key":"1578_CR4","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrc1074","volume":"3","author":"DB Longley","year":"2003","unstructured":"Longley, D. B., Harkin, D. P. & Johnston, P. G. 5-Fluorouracil: mechanisms of action and clinical strategies. Nat. Rev. Cancer 3, 330\u2013338 (2003).","journal-title":"Nat. Rev. Cancer"},{"key":"1578_CR5","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1016\/j.celrep.2016.05.035","volume":"15","author":"Z Ser","year":"2016","unstructured":"Ser, Z. et al. Targeting one carbon metabolism with an antimetabolite disrupts pyrimidine homeostasis and induces nucleotide overflow. Cell Rep. 15, 2367\u20132376 (2016).","journal-title":"Cell Rep."},{"key":"1578_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13041","volume":"7","author":"E Gaude","year":"2016","unstructured":"Gaude, E. & Frezza, C. Tissue-specific and convergent metabolic transformation of cancer correlates with metastatic potential and patient survival. Nat. Commun. 7, 13041 (2016).","journal-title":"Nat. Commun."},{"key":"1578_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan, D. Hallmarks of cancer: new dimensions. Cancer Discov. 12, 31\u201346 (2022).","journal-title":"Cancer Discov."},{"key":"1578_CR8","doi-asserted-by":"publisher","first-page":"eabj3490","DOI":"10.1126\/scisignal.abj3490","volume":"15","author":"DY Moss","year":"2022","unstructured":"Moss, D. Y., McCann, C. & Kerr, E. M. Rerouting the drug response: overcoming metabolic adaptation in KRAS-mutant cancers. Sci. Signal. 15, eabj3490 (2022).","journal-title":"Sci. Signal."},{"key":"1578_CR9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41573-021-00339-6","volume":"21","author":"ZE Stine","year":"2022","unstructured":"Stine, Z. E., Schug, Z. T., Salvino, J. M. & Dang, C. V. Targeting cancer metabolism in the era of precision oncology. Nat. Rev. Drug Discov. 21, 141\u2013162 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1578_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41580-019-0173-8","volume":"21","author":"FJ Bock","year":"2020","unstructured":"Bock, F. J. & Tait, S. W. G. Mitochondria as multifaceted regulators of cell death. Nat. Rev. Mol. Cell Biol. 21, 85\u2013100 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1578_CR11","doi-asserted-by":"publisher","unstructured":"McCann, C. & Kerr, E. M. Metabolic reprogramming: A friend or foe to cancer therapy? Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers13133351 (2021).","DOI":"10.3390\/cancers13133351"},{"key":"1578_CR12","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/ncb2220","volume":"13","author":"LC Gomes","year":"2011","unstructured":"Gomes, L. C., Di Benedetto, G. & Scorrano, L. During autophagy mitochondria elongate, are spared from degradation and sustain cell viability. Nat. Cell Biol. 13, 589\u2013598 (2011).","journal-title":"Nat. Cell Biol."},{"key":"1578_CR13","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1083\/jcb.201511036","volume":"212","author":"P Mishra","year":"2016","unstructured":"Mishra, P. & Chan, D. C. Metabolic regulation of mitochondrial dynamics. J. Cell Biol. 212, 379\u2013387 (2016).","journal-title":"J. Cell Biol."},{"key":"1578_CR14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1091\/mbc.E20-09-0605","volume":"32","author":"R Wang","year":"2021","unstructured":"Wang, R. et al. Identification of new OPA1 cleavage site reveals that short isoforms regulate mitochondrial fusion. Mol. Biol. Cell 32, 157\u2013168 (2021).","journal-title":"Mol. Biol. Cell"},{"key":"1578_CR15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/978-1-4939-8861-7_4","volume":"1877","author":"C Fraser","year":"2019","unstructured":"Fraser, C., Ryan, J. & Sarosiek, K. BH3 profiling: a functional assay to measure apoptotic priming and dependencies. Methods Mol. Biol. 1877, 61\u201376 (2019).","journal-title":"Methods Mol. Biol."},{"key":"1578_CR16","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abc4897","volume":"7","author":"CM Dowling","year":"2021","unstructured":"Dowling, C. M. et al. Multiple screening approaches reveal HDAC6 as a novel regulator of glycolytic metabolism in triple-negative breast cancer. Sci. Adv. 7, eabc4897 (2021).","journal-title":"Sci. Adv."},{"key":"1578_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2013.35","volume":"2","author":"D Ahmed","year":"2013","unstructured":"Ahmed, D. et al. Epigenetic and genetic features of 24 colon cancer cell lines. Oncogenesis 2, e71 (2013).","journal-title":"Oncogenesis"},{"key":"1578_CR18","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature16967","volume":"531","author":"EM Kerr","year":"2016","unstructured":"Kerr, E. M., Gaude, E., Turrell, F. K., Frezza, C. & Martins, C. P. Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities. Nature 531, 110\u2013113 (2016).","journal-title":"Nature"},{"key":"1578_CR19","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/s42255-023-00857-0","volume":"5","author":"J Vande Voorde","year":"2023","unstructured":"Vande Voorde, J. et al. Metabolic profiling stratifies colorectal cancer and reveals adenosylhomocysteinase as a therapeutic target. Nat. Metab. 5, 1303\u20131318 (2023).","journal-title":"Nat. Metab."},{"key":"1578_CR20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ccell.2019.08.003","volume":"36","author":"R Jackstadt","year":"2019","unstructured":"Jackstadt, R. et al. Epithelial NOTCH signaling rewires the tumor microenvironment of colorectal cancer to drive poor-prognosis subtypes and metastasis. Cancer Cell 36, 319\u2013336.e7 (2019).","journal-title":"Cancer Cell"},{"key":"1578_CR21","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/path.4645","volume":"238","author":"R Jackstadt","year":"2016","unstructured":"Jackstadt, R. & Sansom, O. J. Mouse models of intestinal cancer. J. Pathol. 238, 141\u2013151 (2016).","journal-title":"J. Pathol."},{"key":"1578_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40170-022-00285-w","volume":"10","author":"TR Tidwell","year":"2022","unstructured":"Tidwell, T. R., R\u00f8sland, G. V., Tronstad, K. J., S\u00f8reide, K. & Hagland, H. R. Metabolic flux analysis of 3D spheroids reveals significant differences in glucose metabolism from matched 2D cultures of colorectal cancer and pancreatic ductal adenocarcinoma cell lines. Cancer Metab. 10, 9 (2022).","journal-title":"Cancer Metab."},{"key":"1578_CR23","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.cmet.2016.01.007","volume":"23","author":"SM Davidson","year":"2016","unstructured":"Davidson, S. M. et al. Environment impacts the metabolic dependencies of Ras-driven non-small cell lung cancer. Cell Metab. 23, 517\u2013528 (2016).","journal-title":"Cell Metab."},{"key":"1578_CR24","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nbt.3836","volume":"35","author":"J Roper","year":"2017","unstructured":"Roper, J. et al. In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis. Nat. Biotechnol. 35, 569\u2013576 (2017).","journal-title":"Nat. Biotechnol."},{"key":"1578_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nprot.2017.136","volume":"13","author":"J Roper","year":"2018","unstructured":"Roper, J. et al. Colonoscopy-based colorectal cancer modeling in mice with CRISPR\u2013Cas9 genome editing and organoid transplantation. Nat. Protoc. 13, 217\u2013234 (2018).","journal-title":"Nat. Protoc."},{"key":"1578_CR26","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.3390\/cancers14174260","volume":"14","author":"N Vaquero-Siguero","year":"2022","unstructured":"Vaquero-Siguero, N. et al. Modeling colorectal cancer progression reveals niche-dependent clonal selection. Cancers 14, 4260 (2022).","journal-title":"Cancers"},{"key":"1578_CR27","doi-asserted-by":"publisher","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).","journal-title":"Sci. Rep."},{"key":"1578_CR28","doi-asserted-by":"publisher","unstructured":"Leonard, N. A. et al. Tumor-associated mesenchymal stromal cells modulate macrophage phagocytosis in stromal-rich colorectal cancer via PD-1 signaling. iScience https:\/\/doi.org\/10.1016\/j.isci.2024.110701 (2024).","DOI":"10.1016\/j.isci.2024.110701"},{"key":"1578_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13668-3","volume":"11","author":"I Mart\u00ednez-Reyes","year":"2020","unstructured":"Mart\u00ednez-Reyes, I. & Chandel, N. S. Mitochondrial TCA cycle metabolites control physiology and disease. Nat. Commun. 11, 102 (2020).","journal-title":"Nat. Commun."},{"key":"1578_CR30","doi-asserted-by":"publisher","first-page":"25.2.1","DOI":"10.1002\/0471140856.tx2502s60","volume":"60","author":"AS Divakaruni","year":"2014","unstructured":"Divakaruni, A. S., Rogers, G. W. & Murphy, A. N. Measuring mitochondrial function in permeabilized cells using the Seahorse XF analyzer or a Clark-type oxygen electrode. Curr. Protoc. Toxicol. 60, 25.2.1\u201325.2.16 (2014).","journal-title":"Curr. Protoc. Toxicol."},{"key":"1578_CR31","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nprot.2014.018","volume":"9","author":"JK Salabei","year":"2014","unstructured":"Salabei, J. K., Gibb, A. A. & Hill, B. G. Comprehensive measurement of respiratory activity in permeabilized cells using extracellular flux analysis. Nat. Protoc. 9, 421\u2013438 (2014).","journal-title":"Nat. Protoc."},{"key":"1578_CR32","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2015.07.016","volume":"162","author":"K Birsoy","year":"2015","unstructured":"Birsoy, K. et al. An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis. Cell 162, 540\u2013551 (2015).","journal-title":"Cell"},{"key":"1578_CR33","first-page":"5579","volume":"51","author":"AL Jackman","year":"1991","unstructured":"Jackman, A. L. et al. ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study. Cancer Res. 51, 5579\u20135586 (1991).","journal-title":"Cancer Res."},{"key":"1578_CR34","doi-asserted-by":"publisher","first-page":"884S","DOI":"10.3945\/ajcn.110.001917","volume":"93","author":"PJ Fernandez-Marcos","year":"2011","unstructured":"Fernandez-Marcos, P. J. & Auwerx, J. Regulation of PGC-1\u03b1, a nodal regulator of mitochondrial biogenesis. Am. J. Clin. Nutr. 93, 884S\u2013890S (2011).","journal-title":"Am. J. Clin. Nutr."},{"key":"1578_CR35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrm.2017.95","volume":"19","author":"S Herzig","year":"2018","unstructured":"Herzig, S. & Shaw, R. J. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat. Rev. Mol. Cell Biol. 19, 121\u2013135 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1578_CR36","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1042\/EBC20240007","volume":"68","author":"WJ Smiles","year":"2024","unstructured":"Smiles, W. J. et al. New developments in AMPK and mTORC1 cross-talk. Essays Biochem. 68, 321\u2013336 (2024).","journal-title":"Essays Biochem."},{"key":"1578_CR37","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/nature06322","volume":"450","author":"JT Cunningham","year":"2007","unstructured":"Cunningham, J. T. et al. mTOR controls mitochondrial oxidative function through a YY1\u2013PGC-1\u03b1 transcriptional complex. Nature 450, 736\u2013740 (2007).","journal-title":"Nature"},{"key":"1578_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/PO.17.00241","volume":"2","author":"WL Allen","year":"2018","unstructured":"Allen, W. L. et al. Transcriptional subtyping and CD8 immunohistochemistry identifies poor prognosis stage II\/III colorectal cancer patients who benefit from adjuvant chemotherapy. JCO Precis. Oncol. 2, 1\u201315 (2018).","journal-title":"JCO Precis. Oncol."},{"key":"1578_CR39","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon, A. et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics 27, 1739\u20131740 (2011).","journal-title":"Bioinformatics"},{"key":"1578_CR40","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The molecular signatures database hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"1578_CR41","unstructured":"NICE. Colorectal cancer https:\/\/www.nice.org.uk\/guidance\/ng151 (2020)."},{"key":"1578_CR42","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1111\/cas.14532","volume":"111","author":"S Blondy","year":"2020","unstructured":"Blondy, S. et al. 5-Fluorouracil resistance mechanisms in colorectal cancer: from classical pathways to promising processes. Cancer Sci. 111, 3142\u20133154 (2020).","journal-title":"Cancer Sci."},{"key":"1578_CR43","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/1758834015614530","volume":"8","author":"WA Hammond","year":"2016","unstructured":"Hammond, W. A., Swaika, A. & Mody, K. Pharmacologic resistance in colorectal cancer: a review. Ther. Adv. Med. Oncol. 8, 57\u201384 (2016).","journal-title":"Ther. Adv. Med. Oncol."},{"key":"1578_CR44","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk, D. et al. The STRING database in 2023: protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 51, D638\u2013D646 (2023).","journal-title":"Nucleic Acids Res."},{"key":"1578_CR45","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1158\/0008-5472.CAN-03-1101","volume":"64","author":"R Rossignol","year":"2004","unstructured":"Rossignol, R. et al. Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells. Cancer Res. 64, 985\u2013993 (2004).","journal-title":"Cancer Res."},{"key":"1578_CR46","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s10495-020-01637-x","volume":"25","author":"M Orlicka-P\u0142ocka","year":"2020","unstructured":"Orlicka-P\u0142ocka, M., Gurda-Wozna, D., Fedoruk-Wyszomirska, A. & Wyszko, E. Circumventing the Crabtree effect: forcing oxidative phosphorylation (OXPHOS) via galactose medium increases sensitivity of HepG2 cells to the purine derivative kinetin riboside. Apoptosis 25, 835\u2013852 (2020).","journal-title":"Apoptosis"},{"key":"1578_CR47","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.redox.2013.12.028","volume":"2","author":"W Dott","year":"2014","unstructured":"Dott, W., Mistry, P., Wright, J., Cain, K. & Herbert, K. E. Modulation of mitochondrial bioenergetics in a skeletal muscle cell line model of mitochondrial toxicity. Redox Biol. 2, 224\u2013233 (2014).","journal-title":"Redox Biol."},{"key":"1578_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36894-2","volume":"14","author":"B Jim\u00e9nez-G\u00f3mez","year":"2023","unstructured":"Jim\u00e9nez-G\u00f3mez, B. et al. Transgenic NADH dehydrogenase restores oxygen regulation of breathing in mitochondrial complex I-deficient mice. Nat. Commun. 14, 1172 (2023).","journal-title":"Nat. Commun."},{"key":"1578_CR49","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature13110","volume":"508","author":"K Birsoy","year":"2014","unstructured":"Birsoy, K. et al. Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides. Nature 508, 108\u2013112 (2014).","journal-title":"Nature"},{"key":"1578_CR50","doi-asserted-by":"publisher","first-page":"e95","DOI":"10.1093\/nar\/gkl516","volume":"34","author":"D Pye","year":"2006","unstructured":"Pye, D. et al. Production of transmitochondrial cybrids containing naturally occurring pathogenic mtDNA variants. Nucleic Acids Res. 34, e95 (2006).","journal-title":"Nucleic Acids Res."},{"key":"1578_CR51","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41591-022-02103-8","volume":"29","author":"TA Yap","year":"2023","unstructured":"Yap, T. A. et al. Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials. Nat. Med. 29, 115\u2013126 (2023).","journal-title":"Nat. Med."},{"key":"1578_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-014-0082-4","volume":"12","author":"A Luengo","year":"2014","unstructured":"Luengo, A., Sullivan, L. B. & Heiden, M. G. V. Understanding the complex-I-ty of metformin action: limiting mitochondrial respiration to improve cancer therapy. BMC Biol. 12, 82 (2014).","journal-title":"BMC Biol."},{"key":"1578_CR53","doi-asserted-by":"publisher","first-page":"41706","DOI":"10.18632\/oncotarget.5991","volume":"6","author":"C Denise","year":"2015","unstructured":"Denise, C. et al. 5-Fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits. Oncotarget 6, 41706\u201341721 (2015).","journal-title":"Oncotarget"},{"key":"1578_CR54","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.3390\/cancers14061538","volume":"14","author":"RA Almaimani","year":"2022","unstructured":"Almaimani, R. A. et al. In vivo and in vitro enhanced tumoricidal effects of metformin, active vitamin D3, and 5-fluorouracil triple therapy against colon cancer by modulating the PI3K\/Akt\/PTEN\/mTOR network. Cancers 14, 1538 (2022).","journal-title":"Cancers"},{"key":"1578_CR55","doi-asserted-by":"publisher","first-page":"56546","DOI":"10.18632\/oncotarget.17798","volume":"8","author":"SH Kim","year":"2017","unstructured":"Kim, S. H., Kim, S. C. & Ku, J. L. Metformin increases chemo-sensitivity via gene downregulation encoding DNA replication proteins in 5-Fu resistant colorectal cancer cells. Oncotarget 8, 56546\u201356557 (2017).","journal-title":"Oncotarget"},{"key":"1578_CR56","doi-asserted-by":"publisher","first-page":"e84369","DOI":"10.1371\/journal.pone.0084369","volume":"9","author":"P Nangia-Makker","year":"2014","unstructured":"Nangia-Makker, P. et al. Metformin: a potential therapeutic agent for recurrent colon cancer. PLoS ONE 9, e84369 (2014).","journal-title":"PLoS ONE"},{"key":"1578_CR57","doi-asserted-by":"publisher","first-page":"955","DOI":"10.3390\/biomedicines10050955","volume":"10","author":"K-L Yip","year":"2022","unstructured":"Yip, K.-L. et al. Metformin enhancement of therapeutic effects of 5-fluorouracil and oxaliplatin in colon cancer cells and nude mice. Biomedicines 10, 955 (2022).","journal-title":"Biomedicines"},{"key":"1578_CR58","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1158\/1535-7163.MCT-16-0793","volume":"16","author":"N-A Mohamed Suhaimi","year":"2017","unstructured":"Mohamed Suhaimi, N.-A. et al. Metformin inhibits cellular proliferation and bioenergetics in colorectal cancer patient-derived xenografts. Mol. Cancer Ther. 16, 2035\u20132044 (2017).","journal-title":"Mol. Cancer Ther."},{"key":"1578_CR59","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9312149","volume":"2020","author":"J Sang","year":"2020","unstructured":"Sang, J., Tang, R., Yang, M. & Sun, Q. Metformin inhibited proliferation and metastasis of colorectal cancer and presented a synergistic effect on 5-FU. BioMed Res. Int. 2020, 9312149 (2020).","journal-title":"BioMed Res. Int."},{"key":"1578_CR60","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3892\/ol.2022.13431","volume":"24","author":"R Mori","year":"2022","unstructured":"Mori, R., Ukai, J., Tokumaru, Y., Niwa, Y. & Futamura, M. The mechanism underlying resistance to 5-fluorouracil and its reversal by the inhibition of thymidine phosphorylase in breast cancer cells. Oncol. Lett. 24, 311 (2022).","journal-title":"Oncol. Lett."},{"key":"1578_CR61","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1021\/bi102046h","volume":"50","author":"BC Grogan","year":"2011","unstructured":"Grogan, B. C., Parker, J. B., Guminski, A. F. & Stivers, J. T. Effect of the thymidylate synthase inhibitors on dUTP and TTP pool levels and the activities of DNA repair glycosylases on uracil and 5-fluorouracil in DNA. Biochemistry 50, 618\u2013627 (2011).","journal-title":"Biochemistry"},{"key":"1578_CR62","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00280-023-04528-5","volume":"91","author":"J Br\u00e9","year":"2023","unstructured":"Br\u00e9, J. et al. The novel anti-cancer fluoropyrimidine NUC-3373 is a potent inhibitor of thymidylate synthase and an effective DNA-damaging agent. Cancer Chemother. Pharmacol. 91, 401\u2013412 (2023).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"1578_CR63","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41568-023-00557-7","volume":"23","author":"NJ Mullen","year":"2023","unstructured":"Mullen, N. J. & Singh, P. K. Nucleotide metabolism: a pan-cancer metabolic dependency. Nat. Rev. Cancer 23, 275\u2013294 (2023).","journal-title":"Nat. Rev. Cancer"},{"key":"1578_CR64","doi-asserted-by":"publisher","first-page":"115143","DOI":"10.1016\/j.celrep.2024.115143","volume":"44","author":"R Yousefi","year":"2025","unstructured":"Yousefi, R. et al. A microscopy-based screen identifies cellular kinases modulating mitochondrial translation. Cell Rep. 44, 115143 (2025).","journal-title":"Cell Rep."},{"key":"1578_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.115179","volume":"44","author":"BQ Pham","year":"2025","unstructured":"Pham, B. Q., Yi, S. A., Ordureau, A. & An, H. mTORC1 regulates the pyrimidine salvage pathway by controlling UCK2 turnover via the CTLH-WDR26 E3 ligase. Cell Rep. 44, 115179 (2025).","journal-title":"Cell Rep."},{"key":"1578_CR66","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1038\/s41375-019-0461-5","volume":"33","author":"S Christian","year":"2019","unstructured":"Christian, S. et al. The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies. Leukemia 33, 2403\u20132415 (2019).","journal-title":"Leukemia"},{"key":"1578_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2020.100143","volume":"1","author":"R Masoud","year":"2020","unstructured":"Masoud, R. et al. Targeting mitochondrial complex I overcomes chemoresistance in high OXPHOS pancreatic cancer. Cell Rep. Med. 1, 100143 (2020).","journal-title":"Cell Rep. Med."},{"key":"1578_CR68","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","volume":"7","author":"T Farge","year":"2017","unstructured":"Farge, T. et al. Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism. Cancer Discov. 7, 716\u2013735 (2017).","journal-title":"Cancer Discov."},{"key":"1578_CR69","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1053\/j.gastro.2020.08.016","volume":"159","author":"CC Wong","year":"2020","unstructured":"Wong, C. C. et al. In colorectal cancer cells with mutant KRAS, SLC25A22-mediated glutaminolysis reduces DNA demethylation to increase WNT signaling, stemness, and drug resistance. Gastroenterology 159, 2163\u20132180.e6 (2020).","journal-title":"Gastroenterology"},{"key":"1578_CR70","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41419-023-05806-z","volume":"14","author":"J K\u00e4llberg","year":"2023","unstructured":"K\u00e4llberg, J. et al. Intratumor heterogeneity and cell secretome promote chemotherapy resistance and progression of colorectal cancer. Cell Death Dis. 14, 306 (2023).","journal-title":"Cell Death Dis."},{"key":"1578_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111233","volume":"40","author":"E Pranzini","year":"2022","unstructured":"Pranzini, E. et al. SHMT2-mediated mitochondrial serine metabolism drives 5-FU resistance by fueling nucleotide biosynthesis. Cell Rep. 40, 111233 (2022).","journal-title":"Cell Rep."},{"key":"1578_CR72","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1158\/0008-5472.CAN-20-1541","volume":"81","author":"DC Montrose","year":"2021","unstructured":"Montrose, D. C. et al. Exogenous and endogenous sources of serine contribute to colon cancer metabolism, growth, and resistance to 5-fluorouracil. Cancer Res. 81, 2275\u20132288 (2021).","journal-title":"Cancer Res."},{"key":"1578_CR73","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.1038\/s41388-021-01815-4","volume":"40","author":"J Chen","year":"2021","unstructured":"Chen, J. et al. The loss of SHMT2 mediates 5-fluorouracil chemoresistance in colorectal cancer by upregulating autophagy. Oncogene 40, 3974\u20133988 (2021).","journal-title":"Oncogene"},{"key":"1578_CR74","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.3389\/fonc.2019.01282","volume":"9","author":"CY Huang","year":"2019","unstructured":"Huang, C. Y. et al. Glucose metabolites exert opposing roles in tumor chemoresistance. Front. Oncol. 9, 1282 (2019).","journal-title":"Front. Oncol."},{"key":"1578_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4123-1","volume":"18","author":"T Wang","year":"2018","unstructured":"Wang, T. et al. Glycolysis is essential for chemoresistance induced by transient receptor potential channel C5 in colorectal cancer. BMC Cancer 18, 207 (2018).","journal-title":"BMC Cancer"},{"key":"1578_CR76","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1016\/j.cell.2022.07.025","volume":"185","author":"H Kalkavan","year":"2022","unstructured":"Kalkavan, H. et al. Sublethal cytochrome c release generates drug-tolerant persister cells. Cell 185, 3356\u20133374.e22 (2022).","journal-title":"Cell"},{"key":"1578_CR77","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/s41418-022-01022-y","volume":"29","author":"L Sainero-Alcolado","year":"2022","unstructured":"Sainero-Alcolado, L., Lia\u00f1o-Pons, J., Ruiz-P\u00e9rez, M. V. & Arsenian-Henriksson, M. Targeting mitochondrial metabolism for precision medicine in cancer. Cell Death Differ. 29, 1304\u20131317 (2022).","journal-title":"Cell Death Differ."},{"key":"1578_CR78","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/s41416-023-02157-6","volume":"128","author":"R Amirkhah","year":"2023","unstructured":"Amirkhah, R. et al. MmCMS: mouse models\u2019 consensus molecular subtypes of colorectal cancer. Br. J. Cancer 128, 1333\u20131343 (2023).","journal-title":"Br. J. Cancer"},{"key":"1578_CR79","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1042\/bj3480607","volume":"348","author":"MR Owen","year":"2000","unstructured":"Owen, M. R., Doran, E. & Halestrap, A. P. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem. J. 348, 607\u2013614 (2000).","journal-title":"Biochem. J."},{"key":"1578_CR80","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0736-4679(98)00103-6","volume":"16","author":"SC Kwong","year":"1998","unstructured":"Kwong, S. C. & Brubacher, J. Phenformin and lactic acidosis: a case report and review. J. Emerg. Med. 16, 881\u2013886 (1998).","journal-title":"J. Emerg. Med."},{"key":"1578_CR81","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1634\/theoncologist.2018-0442","volume":"24","author":"C Vernieri","year":"2019","unstructured":"Vernieri, C. et al. Impact of metformin use and diabetic status during adjuvant fluoropyrimidine-oxaliplatin chemotherapy on the outcome of patients with resected colon cancer: a TOSCA study subanalysis. Oncologist 24, 385\u2013393 (2019).","journal-title":"Oncologist"},{"key":"1578_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-16677-3","volume":"12","author":"Z Tarhini","year":"2022","unstructured":"Tarhini, Z. et al. The effect of metformin on the survival of colorectal cancer patients with type 2 diabetes mellitus. Sci. Rep. 12, 12374 (2022).","journal-title":"Sci. Rep."},{"key":"1578_CR83","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s00384-020-03676-x","volume":"35","author":"CAW Ng","year":"2020","unstructured":"Ng, C. A. W. et al. Metformin and colorectal cancer: a systematic review, meta-analysis and meta-regression. Int. J. Colorectal Dis. 35, 1501\u20131512 (2020).","journal-title":"Int. J. Colorectal Dis."},{"key":"1578_CR84","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nature15726","volume":"527","author":"E Piskounova","year":"2015","unstructured":"Piskounova, E. et al. Oxidative stress inhibits distant metastasis by human melanoma cells. Nature 527, 186\u2013191 (2015).","journal-title":"Nature"},{"key":"1578_CR85","doi-asserted-by":"publisher","unstructured":"Bezwada, D. et al. Mitochondrial complex I promotes kidney cancer metastasis. Nature https:\/\/doi.org\/10.1038\/s41586-024-07812-3 (2024).","DOI":"10.1038\/s41586-024-07812-3"},{"key":"1578_CR86","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.celrep.2014.06.043","volume":"8","author":"PE Porporato","year":"2014","unstructured":"Porporato, P. E. et al. A mitochondrial switch promotes tumor metastasis. Cell Rep. 8, 754\u2013766 (2014).","journal-title":"Cell Rep."},{"key":"1578_CR87","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41392-018-0011-z","volume":"3","author":"X Sun","year":"2018","unstructured":"Sun, X. et al. Increased mtDNA copy number promotes cancer progression by enhancing mitochondrial oxidative phosphorylation in microsatellite-stable colorectal cancer. Signal Transduct. Target. Ther. 3, 8 (2018).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1578_CR88","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.cmet.2014.09.018","volume":"20","author":"M Foretz","year":"2014","unstructured":"Foretz, M., Guigas, B., Bertrand, L., Pollak, M. & Viollet, B. Metformin: from mechanisms of action to therapies. Cell Metab. 20, 953\u2013966 (2014).","journal-title":"Cell Metab."},{"key":"1578_CR89","unstructured":"National Cancer Institute. Surveillance Research Program https:\/\/cancercontrol.cancer.gov\/overview-highlights\/2021\/progress_srp.html (2021)."},{"key":"1578_CR90","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"1578_CR91","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nature13896","volume":"517","author":"WJ Faller","year":"2015","unstructured":"Faller, W. J. et al. mTORC1-mediated translational elongation limits intestinal tumour initiation and growth. Nature 517, 497\u2013500 (2015).","journal-title":"Nature"},{"key":"1578_CR92","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/nprot.2006.179","volume":"1","author":"V Vichai","year":"2006","unstructured":"Vichai, V. & Kirtikara, K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat. Protoc. 1, 1112\u20131116 (2006).","journal-title":"Nat. Protoc."},{"key":"1578_CR93","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1021\/cb500340w","volume":"9","author":"GW Foight","year":"2014","unstructured":"Foight, G. W., Ryan, J. A., Gull\u00e1, S. V., Letai, A. & Keating, A. E. Designed BH3 peptides with high affinity and specificity for targeting Mcl-1 in cells. ACS Chem. Biol. 9, 1962\u20131968 (2014).","journal-title":"ACS Chem. Biol."},{"key":"1578_CR94","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ymeth.2013.04.006","volume":"61","author":"J Ryan","year":"2013","unstructured":"Ryan, J. & Letai, A. BH3 profiling in whole cells by fluorimeter or FACS. Methods 61, 156\u2013164 (2013).","journal-title":"Methods"},{"key":"1578_CR95","doi-asserted-by":"publisher","first-page":"17808","DOI":"10.1073\/pnas.2001520117","volume":"117","author":"A Lees","year":"2020","unstructured":"Lees, A. et al. The pseudo-caspase FLIP (L) regulates cell fate following p53 activation. Proc. Natl Acad. Sci. USA 117, 17808\u201317819 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Nature Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01578-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01578-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01578-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T22:03:50Z","timestamp":1787177030000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01578-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":95,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["1578"],"URL":"https:\/\/doi.org\/10.1038\/s42255-026-01578-w","relation":{},"ISSN":["2522-5812"],"issn-type":[{"value":"2522-5812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"27 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}